Clinical Trial

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

Name: Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma — clinical trial record (NCT06055816)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated September 28, 2023 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.

Summary

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

Trial Details

NCT Number	NCT06055816
Lead Sponsor	Zhejiang Cancer Hospital
Conditions	Nasopharyngeal Carcinoma
Enrollment	40 participants
Start Date	2023-09-28
Primary Completion	2024-09-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2023-09-28